J0895 HCPCS Level II Code: Injection, deferoxamine mesylate, 500 mg
Coding at a Glance
- Drug products
- 6 NDC products
Medicare Coverage & Payment
- CMS short descriptor: Deferoxamine mesylate inj
- Medicare coverage: Special coverage instructions apply (CMS coverage code D)
- Payment category: Drugs (pricing indicator 51)
- BETOS: O1E — Other drugs
- Last CMS action effective: January 1, 2001
Source: CMS HCPCS Level II release. Coverage codes indicate how Medicare treats the code, not whether a specific claim will be paid; payer policy and documentation still govern.
Change history
- January 1, 1992Added to the code setInjection, deferoxamine mesylate, 500 mg
Drug products (NDC)
CMS ASP NDC-HCPCS Crosswalk · 2026 Q3
Medicare Part B payment limit (ASP + 6%): $10.02
00409-2337-25 — Deferoxamine Mesylate — Pfizer Inc (size 1 × qty 4 (500 MG per billing unit))
60505-6236-06 — Deferoxamine Mesylate — Apotex Corp (size 1 × qty 4 (500 MG per billing unit))
60505-6238-06 — Deferoxamine Mesylate — Apotex Corp (size 1 × qty 4 (500 MG per billing unit))
From the CMS ASP NDC-HCPCS Crosswalk and Part B Payment Limit File. Payment limits apply per HCPCS billing code, not per package.
Contextual Map
Every relationship of J0895 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.
Nearest codes (34)
- J0800 — Injection, corticotropin, up to 40 units[Sibling]
- J0801 — Injection, corticotropin (acthar gel), up to 40 units[Sibling]
- J0802 — Injection, corticotropin (ani), up to 40 units[Sibling]
- J0833 — Injection, cosyntropin, not otherwise specified, 0.25 mg[Sibling]
- J0834 — Injection, cosyntropin, 0.25 mg[Sibling]
- J0840 — Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram[Sibling]
- J0841 — Injection, crotalidae immune f(ab')2 (equine), 120 mg[Sibling]
- J0850 — Injection, cytomegalovirus immune globulin intravenous (human), per vial[Sibling]
- and 26 more
Change history
- January 1, 1992 — Added to the code set [Change history]
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J0895 in its code family, with their registry titles.
- J0889 — Daprodustat, oral, 1 mg, (for esrd on dialysis)
- J0890 — Injection, peginesatide, 0.1 mg (for esrd on dialysis)
- J0891 — Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0892 — Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)
- J0893 — Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg
- J0894 — Injection, decitabine, 1 mg
- J0896 — Injection, luspatercept-aamt, 0.25 mg
- J0897 — Injection, denosumab, 1 mg
- J0898 — Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)
- J0899 — Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)